Načítá se...

Prolonged First-Dose Hypotension Induced by Sacubitril/Valsartan

Entresto was recommanded by major guidelines as the frontline therapy for heart failure with reduced ejection fraction since its clinical benefit was proved by the PARADIGM-HF trial. Angiotensin converting enzyme inhibitors are the cornerstone of the treatment of HF. Varying incidences of first-dose...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Acta Cardiol Sin
Hlavní autoři: Hsiao, Fu-Chih, Chu, Pao-Hsien
Médium: Artigo
Jazyk:Inglês
Vydáno: Taiwan Society of Cardiology 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5777949/
https://ncbi.nlm.nih.gov/pubmed/29375230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6515/ACS.201801_34(1).20170614A
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!